
New York Declares Measles Disaster Emergency as Cases Surge
Oct 05, 2026 20:56 pm UTC| Politics Health Governance
New York Governor Kathy Hochul declared a statewide disaster emergency on Monday in response to a growing measles outbreak, marking the first such declaration by a U.S. state since measles cases began rising sharply in...

Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal
Oct 01, 2026 05:44 am UTC| Business Health
Sanofi SA is expanding its long-running partnership with Regeneron Pharmaceuticals in a deal potentially worth $8 billion, strengthening the French drugmakers pipeline of treatments for inflammatory diseases beyond...

Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
Sep 29, 2026 06:37 am UTC| Business Health
Jiangsu Hengrui Pharmaceuticals shares climbed in Hong Kong on Tuesday after Novo Nordisk agreed to license the Chinese drugmakers experimental obesity and diabetes treatment in a deal potentially worth up to $2.6 billion....

HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
Sep 29, 2026 01:54 am UTC| Business Health Governance
HUTCHMED said Tuesday that AstraZeneca has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval for a combination therapy aimed at treating patients with advanced lung cancer. The...

FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Sep 25, 2026 20:05 pm UTC| Health Governance Business
The U.S. Food and Drug Administration has approved Mirum Pharmaceuticals Atebrioz, a new oral treatment for fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder that causes abnormal bone formation in soft...

Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Sep 25, 2026 06:52 am UTC| Business Health
Novo Nordisk has agreed to pay up to 1.165 billion ($1.37 billion) to license drug-delivery technology from Swedish biotechnology company Nanexa, potentially paving the way for longer-lasting obesity and diabetes...

FDA Weighs Safety Standards for Psychedelic Therapies
Sep 15, 2026 04:30 am UTC| Governance Health
Doctors, veterans, pharmacists and therapists are calling on the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic therapies as the Trump administration seeks to accelerate...